Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06788886 · ClinicalTrials.gov registry record · NA

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

A NA study of Multiple Sclerosis and Malignant Solid Neoplasm, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
147
Enrollment target
1
Study location

NCT06788886: Recruiting NA study of Multiple Sclerosis and Malignant Solid Neoplasm, sponsored by Mayo Clinic.

NCT06788886 is a NA study of Multiple Sclerosis and Malignant Solid Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 147 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06788886, a NA study of Multiple Sclerosis and Malignant Solid Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
147 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies the effect of respiratory training for enhancing brain and mental health among patients with multiple sclerosis (MS) and cancer (along with their caregivers). The relationship between respiration, cardiovascular effects in the brain, mental health, and neurophysiological mechanisms are significant for patient populations facing complex health challenges, such as those with cancer and neurodegenerative disease, and their caregivers. By measuring oxygen delivery to brain tissues and cerebrospinal fluid flow, this trial may help researchers investigate the potential benefits of respiratory training for patients with MS and cancer and their caregivers.

Primary Outcome

Assessed using advanced imaging techniques (such as MRI) and physiological analyses. The approach to data analysis will involve a detailed examination of the MRI data collected from each participant. Respiratory data will be correlated with neuroimaging findings to provide a comprehensive view of how respiratory patterns may influence brain activity.

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Magnetic Resonance Imaging
  • OTHER Questionnaire Administration
  • OTHER Exercise Intervention
  • PROCEDURE Respiratory Therapy

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2025-02-05
Est. Completion 2027-01-18
Phase NA
Mayo Clinic

2,844 total trials

What NCT06788886 shows while recruiting

NCT06788886 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (75% lower).

The record links to 5 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.

NCT06788886 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06788886 about?

NCT06788886 is a clinical study titled "Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases". This clinical trial studies the effect of respiratory training for enhancing brain and mental health among patients with multiple sclerosis (MS) and cancer (along with their caregivers). The relationship between respiration, cardiovascular effects in the brain, mental health, and neurophysiological ...

What is the current status of trial NCT06788886?

This trial is currently recruiting. It is a NA study. The enrollment target is 147 participants. The study started on 2025-02-05. Estimated completion is 2027-01-18.

What conditions does trial NCT06788886 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Malignant Solid Neoplasm, Prostate Carcinoma, Malignant Brain Neoplasm, Neuroendocrine Tumor.

What interventions are being tested in trial NCT06788886?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), Questionnaire Administration (OTHER), Exercise Intervention (OTHER), Respiratory Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT06788886?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06788886 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06788886's enrollment target sits among peer trials

147 98th of 315 higher than 218 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04396613 · 147 participants · NA

    Wound Closure Techniques in Primary Spine Surgery

  • NCT04851119 · 147 participants · Phase 1

    Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NCT05523947 · 147 participants · Phase 1

    Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

  • NCT06121843 · 147 participants · Phase 1

    A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06788886, the US trial registry maintained by the National Library of Medicine. NCT06788886 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.